DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 5.98% to $1.95 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.35% to 18,285.16 and Dow Jones Industrial Average falling 1.55% to 42,520.99.
Inovio Pharmaceuticals Inc. closed 86.78% short of its 52-week high of $14.75, which the company achieved on April 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.11% to $165.42, Statera Biopharma Inc. (STAB) rose 200.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 1.90% to $25.75.
Trading volume (638,667) remained 337,017 below its 50-day average volume of 975,684.
Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2025 17:26 ET (22:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。